- Home
- BVFL vs ANTX Comparison
BVFL vs ANTX Comparison
Compare BVFL & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BVFL | ANTX |
|---|---|---|
| Founded | 1873 | 2017 |
| Country | United States | United States |
| Employees | 104 | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.4M | 172.9M |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BVFL | ANTX |
|---|---|---|
| Price | $21.47 | $4.69 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 12.5K | ★ 190.8K |
| Earning Date | 04-24-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.19 | ★ 32.56 |
| EPS | ★ 0.55 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $38.78 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.60 | $1.00 |
| 52 Week High | $22.17 | $7.19 |
Technical Indicators
Market Signals| Indicator | BVFL | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | N/A |
| Support Level | $20.38 | N/A |
| Resistance Level | $21.92 | N/A |
| Average True Range (ATR) | 0.72 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 67.76 | 0.00 |
Price Performance
Historical ComparisonAbout BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. It operates in one segment commercial banking. The company's sources of revenue are derived from interest and dividends earned on loans and investment securities.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.